• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: report of a case.

作者信息

Miura Koh, Kobayashi Terutada, Funayama Yuji, Fukushima Kouhei, Ogawa Hitoshi, Oyama Atsushi, Itoh Akihiro, Moriya Takuya, Yamada Takayuki, Okumoto Tadayuki, Shibata Chikashi, Sasaki Iwao

机构信息

Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.

出版信息

Surg Today. 2008;38(3):261-5. doi: 10.1007/s00595-007-3592-7. Epub 2008 Feb 29.

DOI:10.1007/s00595-007-3592-7
PMID:18307003
Abstract

A 54-year-old man, with the chief complaints of hematuria, pollakisuria, and pneumaturia, was referred to our hospital, with a diagnosis of giant urinary bladder adenocarcinoma with massive invasion to the rectum. On the basis of the radiological diagnosis and findings of hematoxylin and eosin (H&E) of biopsy specimens, it was difficult to conclude whether the adenocarcinoma originated in the bladder or in the rectum. The immunohistochemical staining of the biopsy specimens showed cytokeratin 7 (CK7)(-) and CK20(+), which supported the notion that the adenocarcinoma possibly originated from the rectum. Although the prognosis of T4 bladder adenocarcinomas has been reported to be quite poor in comparison with that of transitional cell carcinomas, the postoperative prognosis of T4 rectal adenocarcinomas has been reported to be more favorable and such tumors are recommended to be surgically resected. Because no distant metastasis was detected, the patient underwent total pelvic exenteration with a reconstruction of the ileal conduit. Although the resected tumor measured 12 cm in diameter with n1 metastasis, the radial margin was cancer-negative, and the tumor was curatively resected. The immunohistochemical diagnosis of the resected tumor showed carcinoembryonic antigen(+), CK7(-), CK20(+), thrombomodulin(-), and uroplakin(-), which supported the rectal origin. At present the patient is undergoing postoperative adjuvant chemotherapy for rectal cancer.

摘要

相似文献

1
Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: report of a case.
Surg Today. 2008;38(3):261-5. doi: 10.1007/s00595-007-3592-7. Epub 2008 Feb 29.
2
CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.CDX2、细胞角蛋白7和20在直肠腺癌中的免疫反应性。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):196-201. doi: 10.1097/PAI.0b013e31819268f2.
3
[Total Pelvic Exenteration for Local Recurrence of Rectal Cancer Appearing 12 Years after Curative Operation--A Case Report].[直肠癌根治术后12年出现局部复发的全盆腔脏器切除术——病例报告]
Gan To Kagaku Ryoho. 2015 Nov;42(12):2337-9.
4
[Total pelvic exenteration and rectal cancer. Apropos of 20 cases].[全盆腔脏器切除术与直肠癌。附20例报告]
Chirurgie. 1999 Jun;124(3):252-7. doi: 10.1016/s0001-4001(99)80090-7.
5
Laparoscopic anterior pelvic exenteration for locoregionally advanced rectal cancer directly invading the urinary bladder: A case report of low anterior resection with en bloc cystectomy for sphincter preservation.腹腔镜下前盆腔脏器清除术治疗局部进展期直肠癌直接侵犯膀胱:保留括约肌的低位前切除术联合整块膀胱切除术1例报告
Asian J Endosc Surg. 2015 Aug;8(3):343-6. doi: 10.1111/ases.12196.
6
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.免疫组化在膀胱原发性与继发性肠道腺癌鉴别诊断中的应用
Appl Immunohistochem Mol Morphol. 2005 Dec;13(4):358-62. doi: 10.1097/01.pai.0000136552.44045.0f.
7
[A Case of Curatively Resected Rectal Cancer with Preservation of Urinary Function after Chemotherapy].
Gan To Kagaku Ryoho. 2019 Apr;46(4):820-822.
8
Cytokeratin 7 immunoreactivity in rectal adenocarcinomas.
Appl Immunohistochem Mol Morphol. 2003 Dec;11(4):306-10. doi: 10.1097/00129039-200312000-00005.
9
Preoperative cystoscopic findings in resectable rectal adenocarcinoma.可切除直肠腺癌的术前膀胱镜检查结果。
Arch Surg. 1987 Aug;122(8):929-30. doi: 10.1001/archsurg.1987.01400200079014.
10
Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.原发性精囊癌:4例免疫组化分析
Mod Pathol. 2000 Jan;13(1):46-51. doi: 10.1038/modpathol.3880008.

引用本文的文献

1
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.基于 NCBI Literature Survey 和 Human Protein Atlas 数据库的免疫组织化学分析对盆腔器官癌进行直肠癌鉴别。
Surg Today. 2012 Jun;42(6):515-25. doi: 10.1007/s00595-012-0167-z. Epub 2012 Mar 23.

本文引用的文献

1
Second-line treatment of patients with metastatic colorectal cancer.转移性结直肠癌患者的二线治疗
Semin Oncol. 2005 Dec;32(6 Suppl 9):S48-54. doi: 10.1053/j.seminoncol.2005.06.008.
2
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.一项比较吉西他滨联合顺铂与甲氨蝶呤、长春碱、阿霉素联合顺铂治疗膀胱癌患者的随机试验的长期生存结果。
J Clin Oncol. 2005 Jul 20;23(21):4602-8. doi: 10.1200/JCO.2005.07.757.
3
Systemic therapy for metastatic colorectal cancer: current options, current evidence.
转移性结直肠癌的全身治疗:当前选择与现有证据
J Clin Oncol. 2005 Jul 10;23(20):4553-60. doi: 10.1200/JCO.2005.17.749.
4
Aggressive surgical treatment for patients with T4 rectal cancer.
Colorectal Dis. 2003 Sep;5(5):427-31. doi: 10.1046/j.1463-1318.2003.00511.x.
5
Outcome of total pelvic exenteration for primary rectal cancer.原发性直肠癌全盆腔脏器切除术的结果
Dis Colon Rectum. 2003 Apr;46(4):474-80. doi: 10.1007/s10350-004-6585-2.
6
Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.尿路上皮蛋白III、血栓调节蛋白、高分子量细胞角蛋白和细胞角蛋白20在非侵袭性、侵袭性和转移性尿路上皮(移行细胞)癌中的潜在应用价值。
Am J Surg Pathol. 2003 Jan;27(1):1-10. doi: 10.1097/00000478-200301000-00001.
7
High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.人尿路上皮蛋白Ia在膀胱移行细胞癌中的高表达。
Jpn J Cancer Res. 2002 May;93(5):523-31. doi: 10.1111/j.1349-7006.2002.tb01287.x.
8
Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.膀胱原发性腺癌与继发性结直肠癌的免疫组织化学鉴别
Am J Surg Pathol. 2001 Nov;25(11):1380-7. doi: 10.1097/00000478-200111000-00005.
9
Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands.直肠腺癌和正常肛腺中的细胞角蛋白亚群免疫染色
Arch Pathol Lab Med. 2001 Aug;125(8):1074-7. doi: 10.5858/2001-125-1074-CSIIRA.
10
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.细胞角蛋白7和细胞角蛋白20在上皮性肿瘤中的表达:435例病例的调查
Mod Pathol. 2000 Sep;13(9):962-72. doi: 10.1038/modpathol.3880175.